Keyphrases
Peritoneal Surface Malignancy
74%
Chicago
74%
Pathologist
36%
Radiologists
36%
Peritoneal Surface Disease
35%
Palliative Care Physicians
35%
Surgical Oncologist
35%
Medical Oncologist
35%
Pharmacist
35%
Enhanced Awareness
35%
Appropriate Management
35%
Appropriate Use Criteria
32%
Radium
32%
Neoadjuvant Therapy
26%
Preoperative Chemotherapy
21%
Chemoradiation Therapy
20%
Colorectal Cancer
20%
Overall Survival
19%
Pancreaticoduodenectomy
18%
Executive Summary
18%
Radiation Therapy
16%
Hepatocellular Carcinoma
16%
Peritoneal Mesothelioma
16%
Adjuvant Therapy
16%
Chemotherapy
14%
Malignant Peritoneal Mesothelioma
13%
Single Institution
13%
Gastric Adenocarcinoma
13%
Oncologic
13%
Expert Panel
12%
Meta-analysis
12%
Pancreatic Ductal Adenocarcinoma
11%
Gemcitabine
11%
Pancreatic Cancer
11%
National Cancer Database
11%
Intraductal Papillary mucinous Neoplasm
11%
Adjuvant Chemoradiation
11%
Surgical Resection
11%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
10%
Malignancy
10%
Treatment Strategy
10%
Gastric Cancer
10%
Operative Volume
10%
Hepatocellular Carcinoma Patients
9%
Cytoreductive Surgery
9%
Desmoplastic Small Round Cell Tumor (DSRCT)
9%
Non-cardia Gastric Cancer
9%
Programmed Death-ligand 1 (PD-L1)
9%
Neuroendocrine Tumor
9%
Breast
9%
Medicine and Dentistry
Cancer
100%
Oncologist
70%
Diseases
44%
Symptomatic Treatment
36%
Surgery
35%
Pathologist
33%
Awareness
33%
Abdominal Cancer
30%
Systematic Review
27%
Chemoradiation Therapy
25%
Overall Survival
24%
Neoadjuvant Therapy
24%
Radiation Therapy
23%
Hepatocellular Carcinoma
23%
Peritoneum Mesothelioma
23%
Pancreaticoduodenectomy
22%
Neoplasm
20%
Chemoradiotherapy
19%
Metastatic Carcinoma
18%
Stomach Adenocarcinoma
18%
Malignant Neoplasm
17%
Pancreas Adenocarcinoma
16%
Colorectal Carcinoma
15%
Meta-Analysis
14%
Cardia
13%
Intraductal Papillary Mucinous Tumor
11%
Gemcitabine
10%
Adjuvant Chemotherapy
10%
Adjuvant Therapy
9%
Cytoreductive Surgery
9%
Adenocarcinoma
9%
Desmoplastic Small Round Cell Tumor
9%
Neuroendocrine Tumor
9%
Cholangiocarcinoma
9%
Gastrointestinal Stromal Tumor
9%
Ovarian Tumor
9%
Appendix Tumor
9%
Breast Cancer
9%
COVID-19
9%
Immunotherapy
8%
Programmed Death-Ligand 1
7%
Rectum Cancer
7%
Quality of Life
7%
Biopsy Technique
7%
Recurrent Disease
7%
Hazard Ratio
7%
Hepatectomy
7%
Odds Ratio
7%
Pancreatectomy
6%
Univariate Analysis
6%